Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality
Alimentary Pharmacology & Therapeutics · 2024
DOI: 10.1111/apt.17783 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Sung Won Lee und 19 weiteren Autor:innen. Beteiligte Einrichtung: NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms, Elasticity Imaging Techniques. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Progression to cirrhosis in non‐alcoholic steatohepatitis (NASH) is associated with a decrease in liver fat. However, the prognostic significance of liver fat content in NASH‐related significant fibrosis and cirrhosis is unclear.
Aim
To investigate the risk of decompensation, hepatocellular carcinoma (HCC) and mortality stratified by liver fat content in NASH‐related significant fibrosis and cirrhosis.
Methods
In this meta‐analysis of individual participant data, 456 patients with both magnetic resonance elastography (MRE) and MRI‐derived protein density fat fraction (MRI‐PDFF) were enrolled, and 296 patients with longitudinal follow‐up were analysed. MRE combined with fibrosis‐4 (MEFIB‐index), and MRI‐PDFF were used to measure liver fibrosis and fat, respectively. MEFIB‐negative, MEFIB‐positive+ MRI‐PDFF ≥5% and MEFIB‐positive+ MRI‐PDFF
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- NAFLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA.
- Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Division of Gastroenterology, University of California at San Diego, La Jolla, California, USA.
- Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
ORCID-Profile: Sung Won Lee, Daniel Q Huang, Veeral Ajmera, Monica Tincopa, Nobuharu Tamaki, Atsushi Nakajima, Rohit Loomba
Förderung
- NCATS NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- National Center for Advancing Translational Sciences
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Lee, S. W., Huang, D. Q., Bettencourt, R., Ajmera, V., Tincopa, M., Noureddin, N., Amangurbanova, M., Siddiqi, H., Madamba, E., Majzoub, A. M., Nayfeh, T., Tamaki, N., Izumi, N., Nakajima, A., Yoneda, M., Idilman, R., Gumussoy, M., Oz, D. K., Erden, A., & Loomba, R. (2024). Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17783
Vancouver
Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, et al. Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17783
BibTeX
@article{Lee2024,
author = {Lee, Sung Won and Huang, Daniel Q and Bettencourt, Ricki and Ajmera, Veeral and Tincopa, Monica and Noureddin, Nabil and Amangurbanova, Maral and Siddiqi, Harris and Madamba, Egbert and Majzoub, Abdul M and Nayfeh, Tarek and Tamaki, Nobuharu and Izumi, Namiki and Nakajima, Atsushi and Yoneda, Masato and Idilman, Ramzan and Gumussoy, Mesut and Oz, Digdem Kuru and Erden, Ayse and Loomba, Rohit},
title = {Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma , decompensation and mortality},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2024},
doi = {10.1111/apt.17783}
}
EUVIMED